Secondary Myelodysplastic Syndromes

DBCOND0028569Hemic and Lymphatic DiseasesNeoplasms

Secondary Myelodysplastic Syndromes is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Secondary Myelodysplastic Syndrome · Myelodysplastic Syndromes, Secondary
Classified under
Indicated drugs

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
79Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Secondary Myelodysplastic Syndromes share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In